Zoetis Shareholders May Pursue Securities Fraud Lawsuit Over Alleged Misstatements
A securities fraud lawsuit has been filed against Zoetis Inc. (NYSE: ZTS), alleging that the company failed to disclose weakening performance in key products and markets, including Librela, Simparica Trio, Apoquel, and Cytopoint. The suit claims these omissions led to misleading statements about the company's business prospects.
Tickers: $ZTS
Topics: Apoquel Cytopoint FDA warnings lawsuit Librela Simparica Trio Zoetis Inc.